Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence — Revenue, Volume, Production, Trade Analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034 |
|---|---|
| Type Segment | Safety Blood Collection Needles, Standard Blood Collection Needles |
| Application Segment | Hospitals, Clinics, Other |
| Distribution Channel Segment | Direct Sales, Distributors, Online Sales |
|---|---|
| Price range Segment | Low, Medium, Premium |
| Regions & Countries |
|
Rising Prevalence of Chronic Diseases Increasing Safety and Hygiene Standards to Drive Market Growth Government Initiatives and Regulations
High Costs of Advanced Products will limit market growth Competition from Alternative Devices
Growing Technological Advancements Rising Awareness of Infection Control
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
The competitive landscape of the Disposable Blood Collection Needle Market is characterized by several key players focusing on innovation and safety. Major companies, including BD, Terumo, and Medtronic, dominate the market with advanced needle designs featuring safety mechanisms to reduce needlestick injuries. Firms are investing in R&D to develop eco-friendly and technologically advanced products, while strategic partnerships and mergers enhance market presence. Regulatory compliance and the adoption of stringent safety standards further influence competition, driving manufacturers to differentiate their offerings.
In February 2022, Takeda has obtained approval from the United States Food and Drug Administration for the TAKHZYRO (lanadelumab-flyo) injection, available in a single-dose prefilled syringe (PFS), aimed at preventing hereditary angioedema (HAE) attacks. (Source: https://www.takeda.com/en-us/newsroom/news-releases/2022/takeda-receives-us-fda-approval-for-prefilled-syringe-presentation-of-takhzyro/) In April 2023, Roche Diabetes Care has introduced ACCU-FINE pen needles designed for painless insulin delivery. This product facilitates smoother insulin administration, ultimately contributing to improved diabetes management for individuals living with diabetes. (Source: https://drugscontrol.org/news-detail.php?newsid=32773) In April 2023, Becton, Dickinson and Company has launched a groundbreaking needle-free blood draw technology designed to integrate seamlessly with catheters. The PIVO Pro Needle-free Blood Collection Device has received 510(k) clearance from the U.S. Food and Drug Administration. This device is the first of its kind, featuring unique compatibility with integrated and extended peripheral IV catheters. (Source: https://www.bd.com/en-us/products-and-solutions/products/product-families/pivo-pro-needle-free-blood-draw-device)
| Company | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| BD (Becton | ••• | ••• | ••• | ••• |
| Dickinson and Company) | ••• | ••• | ••• | ••• |
| Terumo Corporation | ••• | ••• | ••• | ••• |
| Medtronic plc | ••• | ••• | ••• | ••• |
| F.L. Medical | ••• | ••• | ••• | ••• |
| Greiner Bio-One International GmbH | ••• | ••• | ••• | ••• |
| Nipro Corporation | ••• | ••• | ••• | ••• |
| Smiths Medical | ••• | ••• | ••• | ••• |
| Henke-Sass | ••• | ••• | ••• | ••• |
| Wolf GmbH | ••• | ••• | ••• | ••• |
| VYGON S.A. | ••• | ••• | ••• | ••• |
| Hirschmann Laborgeräte GmbH | ••• | ••• | ••• | ••• |
| Cypress Diagnostic Inc. | ••• | ••• | ••• | ••• |
| Sarstedt AG & Co. | ••• | ••• | ••• | ••• |
| Boston Scientific Corporation | ••• | ••• | ••• | ••• |
| Parker Hannifin Corporation | ••• | ••• | ••• | ••• |
| Shandong Weigao Group Medical Polymer Company Limited | ••• | ••• | ••• | ••• |
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
Request company profile for validation →According to Cognitive Market Research, the global Disposable Blood Collection Needle market size was USD xx million in 2024. It will expand at a compound annual growth rate (CAGR) of 6.00% from 2024 to 2031.
The Disposable Blood Collection Needle Market is experiencing steady growth due to the increasing prevalence of chronic diseases, rising safety and hygiene standards, and expanding healthcare infrastructure globally. Chronic conditions like diabetes and cardiovascular disorders necessitate frequent blood tests, driving demand for single-use, sterile needles to prevent cross-contamination and infections. Technological advancements in needle design, including safety features like retractable mechanisms, enhance their appeal. Additionally, the healthcare sector's focus on infection control, particularly post-COVID-19, further boosts the market. Trends such as the adoption of eco-friendly, recyclable materials and growing regulatory support for safety-engineered devices are shaping the market. Despite high costs associated with advanced products, the overall demand for safer and more efficient blood collection methods continues to propel the market forward.
In February 2022, Owen Mumford Pharmaceutical Services has introduced the UniSafe 1mL safety device for pre-filled syringes, which has received approval as a combination product in Asia. (Source: https://www.owenmumford.com/en/owen-mumford-announces-market-release-unisafer-1ml-safety-device-pre-filled-syringes-featuring)
Conclusion
Conclusion
★ Reviews
Rate this report
| Type | Safety Blood Collection Needles, Standard Blood Collection Needles |
| Application | Hospitals, Clinics, Other |
| Distribution Channel | Direct Sales, Distributors, Online Sales |
| Price range | Low, Medium, Premium |
| List of Competitors | BD (Becton, Dickinson and Company), Terumo Corporation, Medtronic plc, F.L. Medical, Greiner Bio-One International GmbH, Nipro Corporation, Smiths Medical, Henke-Sass, Wolf GmbH, VYGON S.A., Hirschmann Laborgeräte GmbH, Cypress Diagnostic Inc., Sarstedt AG & Co., Boston Scientific Corporation, Parker Hannifin Corporation, Shandong Weigao Group Medical Polymer Company Limited |
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Global Disposable Blood Collection Needle Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Global Disposable Blood Collection Needle Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the global disposable blood collection needle market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.